---
layout: post
title: "Supplements to Sickle Cell Disease Newborn Screening Follow-up Program Recipients (HRSA-21-036)"
date: 2026-02-05 18:56:31 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2023-17805
original_published: 2023-08-18 00:00:00 +0000
significance: 8.00
---

# Supplements to Sickle Cell Disease Newborn Screening Follow-up Program Recipients (HRSA-21-036)

**Published:** February 05, 2026 18:56 UTC
**Source:** Federal Register
**Original Published:** August 18, 2023 00:00 UTC
**Document Number:** 2023-17805

## Summary

HRSA will provide supplemental award funds to all 25 Sickle Cell Disease (SCD) Newborn Screening (NBS) Follow-up Program (FP) grantees for $56,000 each for fiscal year 2023. The funds will support in-scope grant activities related to health care services, increasing access to medical and social support services, and conducting outreach to help connect individuals living with SCD to follow-up care.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/08/18/2023-17805/supplements-to-sickle-cell-disease-newborn-screening-follow-up-program-recipients-hrsa-21-036)
- API: https://www.federalregister.gov/api/v1/documents/2023-17805

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
